Thomas P. Hastings-Tickerhoff

Thomas P. Hastings-Tickerhoff serves as a Contracting Officer responsible for managing the acquisition of biological products, with a primary focus on the manufacturing of non-diagnostic biological substances. In this role, he ensures compliance with federal procurement regulations while facilitating the timely and efficient acquisition of critical biomedical materials essential to public health and national security missions. His procurement activities encompass full lifecycle contract management—from solicitation and evaluation to award and administration—typically involving complex, highly regulated scientific and manufacturing requirements. He works closely with technical stakeholders to define performance specifications and ensure contractual alignment with federal standards for quality, safety, and traceability. Hastings-Tickerhoff maintains a streamlined contracting approach, partnering with a select group of qualified manufacturers possessing validated cGMP capabilities and robust quality assurance systems. While no single contractor dominates his portfolio, his relationships are characterized by long-term, performance-based engagements with firms capable of meeting stringent regulatory requirements under FDA oversight. He prioritizes contractual clarity, risk mitigation, and supply chain resilience, often employing indefinite-delivery/indefinite-quantity (IDIQ) and cost-reimbursement instruments to accommodate variable production demands. His procurement pattern reflects a strong preference for unrestricted competition, with 100% of awards issued under the “No Set-Aside” category. This indicates a focus on technical capability and regulatory compliance over socioeconomic classifications, suggesting a mission-critical environment where product integrity and manufacturing scale take precedence over socioeconomic set-asides. His expertise is narrowly concentrated in NAICS 325414—Biological Product (except Diagnostic) Manufacturing—where he procures vaccines, therapeutic proteins, cell and gene therapies, and other biologics requiring controlled production environments. He possesses deep familiarity with biomanufacturing processes, sterile processing, cold chain logistics, and biosafety protocols, making him a specialized procurement professional within the biomedical supply chain.